Aprea Therapeutics hosts virtual panel on WEE1 inhibition in precision oncology
APRE•Aprea Therapeutics will host a virtual panel on WEE1 inhibition in precision oncology on Oct. 20, 2026, at 11 a.m. ET.
1. Panel scheduled
The pre-ESMO Congress panel will examine WEE1 biology, inhibitor selectivity challenges and the clinical outlook.
